相关实验视频
Updated: Jul 5, 2025

10:40
CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
2.4K
在局部性前列腺癌中发生基因突变的生殖线DNA损伤反应
Tomas Januskevicius1, Ieva Vaicekauskaite2,3, Rasa Sabaliauskaite2,3
1Clinic of Gastroenterology, Nephro-Urology and Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, M. K. Ciurlionio St. 21/27, LT-03101 Vilnius, Lithuania.
Medicina (Kaunas, Lithuania)
|January 23, 2024
概括
生殖线DNA损伤反应 (DDR) 基因突变增加前列腺癌 (PCa) 风险. 对DDR突变的基因查可能有助于早期识别攻击性PCa病例,特别是在局部疾病中.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 生殖线DNA损伤反应 (DDR) 基因突变与更高的前列腺癌 (PCa) 风险和更具攻击性的疾病有关.
- 虽然DDR突变测试是转移性PCa的标准,但关于其在早期局部PCa的流行率的数据有限.
研究的目的:
- 为了前性地确定局部PCa.中的DDR路径突变.
- 为了将这些突变与临床,组织病理学和放射学数据相关联.
- 为了将发现与一组先进的PCa病例进行比较.
主要方法:
- 在139位局部PCa患者中对生殖线DDR基因突变的前性评估.
- 一个由五个基因组成的小组 (BRCA1,BRCA2,ATM,CHEK2,NBN) 的下一代定向测序.
主要成果:
- 在突变载体中观察到局部PCa的风险近三倍 (OR 2.84).
- 生殖线DDR突变的患病率为16.8%,仅在PI-RADS 4/5病变中.
- 与CHEK2载体相比,BRCA1/BRCA2/ATM载体的cISUP等级> 1的可能性更高.
结论:
- 针对特定的DDR基因突变进行基因查可能有助于早期识别患有侵袭性PCa风险的个体.
- 这些发现突显了生殖线DDR突变分析在局部PCa管理中的潜在实用性.
更多相关视频
相关概念视频
Nucleotide Excision Repair
3.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K
Mutations
82.4K
Overview
82.4K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K

